A retrospective, cross-sectional study reveals that women with crswnp have more severe disease than men

Whitney Stevens, Anju Tripathi Peters, Lydia Suh, James E. Norton, Robert C Kern, David B Conley Jr, Rakesh K. Chandra, Bruce Kuang-Huay Tan, Leslie C Grammer III, Kathleen E. Harris, Roderick G. Carter, Atsushi Kato, Margrit Urbanek, Robert P Schleimer, Kathryn E Hulse*

*Corresponding author for this work

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Up to 50% of patients with chronic rhinosinusitis (CRS) have comorbid asthma, and we have reported that a subset of CRS patients who have nasal polyps (CRSwNP) have elevated autoantigen-specific antibodies within their nasal polyps (NP). While increases in the prevalence and/or severity of both asthma and autoimmunity in women are well characterized, it is not known whether CRSwNP is more severe or frequent in women than men. We sought to determine whether CRSwNP demonstrated sex-specific differences in frequency and/or severity. Using a retrospectively collected database of tertiary care patients (n = 1393), we evaluated the distribution of sex in patients with CRSwNP with or without comorbid asthma or aspirin hypersensitivity. We further compared the severity of sinus disease between men and women with CRSwNP. Although women comprised 55% of CRS patients without NP (CRSsNP), a significantly smaller proportion of CRSwNP patients were female (38%, P < 0.001). Interestingly, women with CRSwNP were significantly more likely than men to have comorbid asthma (P < 0.001), and 61% of patients with the most severe form of disease (aspirin-exacerbated respiratory disease (CRSwNP plus asthma plus aspirin sensitivity)) were women (P < 0.05). Women with CRSwNP were significantly more likely to have taken oral steroids, and were more likely to have a history of revision surgeries (P < 0.05) compared to men. These data suggest that women with CRSwNP have more severe disease than men in a tertiary care setting. Future studies are needed to elucidate the mechanisms that drive disease severity in men and women, paving the way for the development of personalized treatment strategies for CRSwNP based on sex.

Original languageEnglish (US)
Pages (from-to)14-22
Number of pages9
JournalImmunity Inflammation and Disease
Volume3
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Nasal Polyps
Cross-Sectional Studies
Asthma
Aspirin
Tertiary Healthcare
Sex Distribution
Autoantigens
Autoimmunity
Reoperation
Sex Characteristics
Hypersensitivity

Keywords

  • AERD
  • Asthma
  • Chronic inflammation
  • Chronic rhinosinusitis
  • Oral steroids

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{402c014cf98544349c6232625ab01200,
title = "A retrospective, cross-sectional study reveals that women with crswnp have more severe disease than men",
abstract = "Up to 50{\%} of patients with chronic rhinosinusitis (CRS) have comorbid asthma, and we have reported that a subset of CRS patients who have nasal polyps (CRSwNP) have elevated autoantigen-specific antibodies within their nasal polyps (NP). While increases in the prevalence and/or severity of both asthma and autoimmunity in women are well characterized, it is not known whether CRSwNP is more severe or frequent in women than men. We sought to determine whether CRSwNP demonstrated sex-specific differences in frequency and/or severity. Using a retrospectively collected database of tertiary care patients (n = 1393), we evaluated the distribution of sex in patients with CRSwNP with or without comorbid asthma or aspirin hypersensitivity. We further compared the severity of sinus disease between men and women with CRSwNP. Although women comprised 55{\%} of CRS patients without NP (CRSsNP), a significantly smaller proportion of CRSwNP patients were female (38{\%}, P < 0.001). Interestingly, women with CRSwNP were significantly more likely than men to have comorbid asthma (P < 0.001), and 61{\%} of patients with the most severe form of disease (aspirin-exacerbated respiratory disease (CRSwNP plus asthma plus aspirin sensitivity)) were women (P < 0.05). Women with CRSwNP were significantly more likely to have taken oral steroids, and were more likely to have a history of revision surgeries (P < 0.05) compared to men. These data suggest that women with CRSwNP have more severe disease than men in a tertiary care setting. Future studies are needed to elucidate the mechanisms that drive disease severity in men and women, paving the way for the development of personalized treatment strategies for CRSwNP based on sex.",
keywords = "AERD, Asthma, Chronic inflammation, Chronic rhinosinusitis, Oral steroids",
author = "Whitney Stevens and Peters, {Anju Tripathi} and Lydia Suh and Norton, {James E.} and Kern, {Robert C} and {Conley Jr}, {David B} and Chandra, {Rakesh K.} and Tan, {Bruce Kuang-Huay} and {Grammer III}, {Leslie C} and Harris, {Kathleen E.} and Carter, {Roderick G.} and Atsushi Kato and Margrit Urbanek and Schleimer, {Robert P} and Hulse, {Kathryn E}",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/iid3.46",
language = "English (US)",
volume = "3",
pages = "14--22",
journal = "Immunity, inflammation and disease",
issn = "2050-4527",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - A retrospective, cross-sectional study reveals that women with crswnp have more severe disease than men

AU - Stevens, Whitney

AU - Peters, Anju Tripathi

AU - Suh, Lydia

AU - Norton, James E.

AU - Kern, Robert C

AU - Conley Jr, David B

AU - Chandra, Rakesh K.

AU - Tan, Bruce Kuang-Huay

AU - Grammer III, Leslie C

AU - Harris, Kathleen E.

AU - Carter, Roderick G.

AU - Kato, Atsushi

AU - Urbanek, Margrit

AU - Schleimer, Robert P

AU - Hulse, Kathryn E

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Up to 50% of patients with chronic rhinosinusitis (CRS) have comorbid asthma, and we have reported that a subset of CRS patients who have nasal polyps (CRSwNP) have elevated autoantigen-specific antibodies within their nasal polyps (NP). While increases in the prevalence and/or severity of both asthma and autoimmunity in women are well characterized, it is not known whether CRSwNP is more severe or frequent in women than men. We sought to determine whether CRSwNP demonstrated sex-specific differences in frequency and/or severity. Using a retrospectively collected database of tertiary care patients (n = 1393), we evaluated the distribution of sex in patients with CRSwNP with or without comorbid asthma or aspirin hypersensitivity. We further compared the severity of sinus disease between men and women with CRSwNP. Although women comprised 55% of CRS patients without NP (CRSsNP), a significantly smaller proportion of CRSwNP patients were female (38%, P < 0.001). Interestingly, women with CRSwNP were significantly more likely than men to have comorbid asthma (P < 0.001), and 61% of patients with the most severe form of disease (aspirin-exacerbated respiratory disease (CRSwNP plus asthma plus aspirin sensitivity)) were women (P < 0.05). Women with CRSwNP were significantly more likely to have taken oral steroids, and were more likely to have a history of revision surgeries (P < 0.05) compared to men. These data suggest that women with CRSwNP have more severe disease than men in a tertiary care setting. Future studies are needed to elucidate the mechanisms that drive disease severity in men and women, paving the way for the development of personalized treatment strategies for CRSwNP based on sex.

AB - Up to 50% of patients with chronic rhinosinusitis (CRS) have comorbid asthma, and we have reported that a subset of CRS patients who have nasal polyps (CRSwNP) have elevated autoantigen-specific antibodies within their nasal polyps (NP). While increases in the prevalence and/or severity of both asthma and autoimmunity in women are well characterized, it is not known whether CRSwNP is more severe or frequent in women than men. We sought to determine whether CRSwNP demonstrated sex-specific differences in frequency and/or severity. Using a retrospectively collected database of tertiary care patients (n = 1393), we evaluated the distribution of sex in patients with CRSwNP with or without comorbid asthma or aspirin hypersensitivity. We further compared the severity of sinus disease between men and women with CRSwNP. Although women comprised 55% of CRS patients without NP (CRSsNP), a significantly smaller proportion of CRSwNP patients were female (38%, P < 0.001). Interestingly, women with CRSwNP were significantly more likely than men to have comorbid asthma (P < 0.001), and 61% of patients with the most severe form of disease (aspirin-exacerbated respiratory disease (CRSwNP plus asthma plus aspirin sensitivity)) were women (P < 0.05). Women with CRSwNP were significantly more likely to have taken oral steroids, and were more likely to have a history of revision surgeries (P < 0.05) compared to men. These data suggest that women with CRSwNP have more severe disease than men in a tertiary care setting. Future studies are needed to elucidate the mechanisms that drive disease severity in men and women, paving the way for the development of personalized treatment strategies for CRSwNP based on sex.

KW - AERD

KW - Asthma

KW - Chronic inflammation

KW - Chronic rhinosinusitis

KW - Oral steroids

UR - http://www.scopus.com/inward/record.url?scp=84992604507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992604507&partnerID=8YFLogxK

U2 - 10.1002/iid3.46

DO - 10.1002/iid3.46

M3 - Article

VL - 3

SP - 14

EP - 22

JO - Immunity, inflammation and disease

JF - Immunity, inflammation and disease

SN - 2050-4527

IS - 1

ER -